Market Overview
The hospital-acquired infection control market is expected to grow at a CAGR of 1.5 percent to USD 31.3 billion by 2030, up from USD 29.1 billion in 2023. The high incidence of hospital-acquired infections, the increasing number of surgical procedures, the growing geriatric population and the increasing incidence of chronic diseases, technological advancements in sterilization equipment, and the growing awareness of environmental as well as personal hygiene because of the COVID-19 are all boosting the growth of the hospital-acquired infection control market. During the projection period, the increasing usage of E-beam sterilization, the reintroduction of ethylene oxide sterilization, the developing healthcare industry, and the outsourcing of operations to emerging nations are projected to provide market players with high-growth possibilities.
Hospital-acquired infections, also known as nosocomial infections, are infections that occur in hospitals and other healthcare settings. These infections could happen up to 48 hours post-admission to the hospital, 3 days after discharge, or up to 30 days after an operation or in a healthcare institution if the patient was hospitalized for reasons apart from infection.
With the occurrence of many epidemics and pandemics around the world, many nations' governments are beefing up their healthcare infrastructure in preparation for any breakout. Many people are receiving treatment in hospitals due to improved reimbursement rules that allow every citizen to access high-quality healthcare. This factor will eventually increase the market's growth prospects for hospital-acquired infection control.
Competitive Outlook
As per the Hospital-Acquired Infections Market Trends report, the presence of key players in different regions is contributing effectively to the worldwide market during the assessment period. These bigger market players include:
Advanced Sterilization Products,
Becton Dickinson and company,
Belimed AG,
3M Company,
Cantel Medical Corp.,
Getinge AB,
STERIS Corporation.
Market Segmentation
The global Hospital Acquired Infections Market Size have been classified by pathogen type, which includes viral, bacterial, and fungal diseases. The market is divided into sterilization, radiation, and chemical treatment methods and infection types such as urinary tract infections, surgical site infections, bloodstream infections, gastrointestinal infections, and respiratory infections.
Industry News
Except for bacterial spores from inanimate items, disinfection is defined as a technique that destroys many or all pathogenic microorganisms. Wet pasteurization or liquid chemicals are used to accomplish this. Several factors have influenced disinfection efficiency, each of which may limit the process' efficacy.
Early cleaning of the object, the organic load on the item, the type and level of microbial impurity, the physical configuration of the object (e.g., hinges, crevices, and lumens), the concentration of germicide exposure time, and the pH and temperature of the disinfection process are among the factors that have been shown to impact disinfection efficacy. The Food and Drug Administration (FDA) in the United States keeps track of high-level disinfectants that can be used to reprocess heat-sensitive medical devices like flexible endoscopes.
Regional Classification
HAI is more common in the Mediterranean and Southeast Asia. Norway, which is located towards the northernmost tip of the Northern Hemisphere, has the lowest occurrence of HAI. The hospital market-acquired infections in America are the largest globally, with a projected value of $12 billion by the end of the forecast period in 2022. This market has been growing since 2016. Hence the growth period for this market may be defined as 2016 to 2022—the second-largest market for hospital-acquired illnesses in Europe. In the market for hospital-acquired infections, the Asia Pacific region is predicted to develop at the quickest rate.
Market Research Future's report on the hospital-acquired infection market includes thorough primary research and detailed qualitative and quantitative analysis by various industry experts and key opinion leaders to achieve a better understanding of the industry and market performance.
About US:
Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
